Status:
TERMINATED
Breast Magnetic Resonance Imaging (MRI) Screening After Mantle Radiation Therapy
Lead Sponsor:
M.D. Anderson Cancer Center
Conditions:
Breast Cancer
Eligibility:
FEMALE
Brief Summary
Objectives: The objective of this single-arm, prospective study is to perform annual mammography and MRI breast cancer screening in women who underwent mantle-field irradiation between 1970-1995 at M...
Detailed Description
Breast MRIs: Breast MRIs have been reported to have higher sensitivity than mammograms for detecting early breast cancers, particularly in dense breasts where mammograms are not as effective. Althoug...
Eligibility Criteria
Inclusion
- Female patients diagnosed with lymphoma prior to 1995
- The radiation therapy must have been delivered at M.D. Anderson from start to finish with complete records of dose received
- Patients must have received radiation therapy to the chest between the ages of 10 and 30
Exclusion
- Patients with claustrophobia
- Obese patients (the equipment weight limit is 350 pounds and the maximum scanner bore diameter is 55 cm)
- Patients with myocardial infarction within 6 months of study entry
- Patients with unstable angina pectoris, uncontrolled congestive heart failure, or uncontrolled arrhythmias
- Patients with aneurysm clips, pacemakers, or other implanted devices that are not MRI compatible
- Pregnant patients
- Patients with compromised renal function, with a calculated glomerular filtration rate (cGFR) less than 60 ml/min/1.73m2.
- Patients who began their treatment outside of MD Anderson Cancer Center.
Key Trial Info
Start Date :
June 1 2009
Trial Type :
OBSERVATIONAL
Allocation :
ACTUAL
End Date :
October 1 2011
Estimated Enrollment :
10 Patients enrolled
Trial Details
Trial ID
NCT00925405
Start Date
June 1 2009
End Date
October 1 2011
Last Update
November 8 2011
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
UT MD Anderson Cancer Center
Houston, Texas, United States, 77030